Literature DB >> 18324364

MR-optical imaging of cardiovascular molecular targets.

Matthias Nahrendorf1, David E Sosnovik, Ralph Weissleder.   

Abstract

Our understanding of the intricate inflammation biology underlying atherosclerosis is rapidly progressing. Molecular imaging strategies, harnessing this body of knowledge, have been developed to visualize some key cellular and molecular events in plaque evolution and vulnerability. Here, we discuss recent advances in magnetic resonance and fluorescence imaging of key biomarkers including adhesion molecules, inflammatory cells, and enzyme activity. We discuss strengths and limitations of respective imaging technologies, and comment on the potential of multi-modality imaging approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324364      PMCID: PMC2664635          DOI: 10.1007/s00395-008-0707-2

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  43 in total

1.  Fluorescence molecular tomography resolves protease activity in vivo.

Authors:  Vasilis Ntziachristos; Ching-Hsuan Tung; Christoph Bremer; Ralph Weissleder
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440

Review 2.  Shedding light onto live molecular targets.

Authors:  Ralph Weissleder; Vasilis Ntziachristos
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

3.  Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease.

Authors:  Elena Aikawa; Matthias Nahrendorf; David Sosnovik; Vincent M Lok; Farouc A Jaffer; Masanori Aikawa; Ralph Weissleder
Journal:  Circulation       Date:  2007-01-15       Impact factor: 29.690

4.  In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques.

Authors:  C Yuan; L M Mitsumori; M S Ferguson; N L Polissar; D Echelard; G Ortiz; R Small; J W Davies; W S Kerwin; T S Hatsukami
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

5.  Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits.

Authors:  S A Schmitz; S E Coupland; R Gust; S Winterhalter; S Wagner; M Kresse; W Semmler; K J Wolf
Journal:  Invest Radiol       Date:  2000-08       Impact factor: 6.016

6.  Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging.

Authors:  M E Kooi; V C Cappendijk; K B J M Cleutjens; A G H Kessels; P J E H M Kitslaar; M Borgers; P M Frederik; M J A P Daemen; J M A van Engelshoven
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

7.  Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging.

Authors:  Jörg Barkhausen; Wolfgang Ebert; Claudia Heyer; Jörg F Debatin; Hanns-Joachim Weinmann
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

Review 8.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  In vivo imaging of proteolytic activity in atherosclerosis.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Umar Mahmood; Vasilis Ntziachristos; Robert Gyurko; Mark C Fishman; Paul L Huang; Ralph Weissleder
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

10.  Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma.

Authors:  Silvio Litovsky; Mohammad Madjid; Alireza Zarrabi; S Ward Casscells; James T Willerson; Morteza Naghavi
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

View more
  11 in total

Review 1.  Magnetic nanoparticles in magnetic resonance imaging and diagnostics.

Authors:  Christine Rümenapp; Bernhard Gleich; Axel Haase
Journal:  Pharm Res       Date:  2012-03-06       Impact factor: 4.200

Review 2.  CMR for characterization of the myocardium in acute coronary syndromes.

Authors:  Erica Dall'Armellina; Theodoros D Karamitsos; Stefan Neubauer; Robin P Choudhury
Journal:  Nat Rev Cardiol       Date:  2010-09-21       Impact factor: 32.419

3.  Human ferritin cages for imaging vascular macrophages.

Authors:  Masahiro Terashima; Masaki Uchida; Hisanori Kosuge; Philip S Tsao; Mark J Young; Steven M Conolly; Trevor Douglas; Michael V McConnell
Journal:  Biomaterials       Date:  2010-11-11       Impact factor: 12.479

4.  Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.

Authors:  Tong Lu; Song Wen; Ying Cui; Sheng-Hong Ju; King C Li; Gao-Jun Teng
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-30       Impact factor: 2.357

5.  Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions.

Authors:  Masaki Uchida; Hisanori Kosuge; Masahiro Terashima; Deborah A Willits; Lars O Liepold; Mark J Young; Michael V McConnell; Trevor Douglas
Journal:  ACS Nano       Date:  2011-03-21       Impact factor: 15.881

Review 6.  Recent advances in small-animal cardiovascular imaging.

Authors:  Benjamin M W Tsui; Dara L Kraitchman
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

7.  Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.

Authors:  Gunter Almer; Karin Wernig; Matthias Saba-Lepek; Samih Haj-Yahya; Johannes Rattenberger; Julian Wagner; Kerstin Gradauer; Daniela Frascione; Georg Pabst; Gerd Leitinger; Harald Mangge; Andreas Zimmer; Ruth Prassl
Journal:  Int J Nanomedicine       Date:  2011-06-21

8.  Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.

Authors:  Gunter Almer; Daniela Frascione; Isabella Pali-Schöll; Caroline Vonach; Anna Lukschal; Caroline Stremnitzer; Susanne C Diesner; Erika Jensen-Jarolim; Ruth Prassl; Harald Mangge
Journal:  Mol Pharm       Date:  2012-12-04       Impact factor: 4.939

9.  Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance.

Authors:  Anthony Dellinger; John Olson; Kerry Link; Stephen Vance; Marinella G Sandros; Jijin Yang; Zhiguo Zhou; Christopher L Kepley
Journal:  J Cardiovasc Magn Reson       Date:  2013-01-16       Impact factor: 5.364

10.  Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.

Authors:  Gunter Almer; Kelli L Summers; Bernhard Scheicher; Josef Kellner; Ingeborg Stelzer; Gerd Leitinger; Anna Gries; Ruth Prassl; Andreas Zimmer; Harald Mangge
Journal:  Int J Nanomedicine       Date:  2014-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.